Oxidative stress in vascular disease:: causes, defense mechanisms and potential therapies

被引:438
作者
Foerstermann, Ulrich [1 ]
机构
[1] Johannes Gutenberg Univ Mainz, Dept Pharmacol, D-55101 Mainz, Germany
来源
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE | 2008年 / 5卷 / 06期
关键词
angiotensin 1 receptor antagonists; endothelial nitric oxide synthase; reactive oxygen species; statins; vitamins;
D O I
10.1038/ncpcardio1211
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Endothelial cells control vascular homeostasis by generating paracrine factors that regulate vascular tone, inhibit platelet function, prevent adhesion of leukocytes, and limit proliferation of vascular smooth muscle. The dominant factor responsible for many of those effects is endothelium-derived nitric oxide (NO). Endothelial dysfunction characterized by enhanced inactivation or reduced synthesis of NO, alone or in combination, is seen in conjunction with risk factors for cardiovascular disease. Endothelial dysfunction can promote vasospasm, thrombosis, vascular inflammation, and proliferation of the intima. Vascular oxidative stress and increased production of reactive oxygen species contributes to mechanisms of vascular dysfunction. Oxidative stress is mainly caused by an imbalance between the activity of endogenous pro-oxidative enzymes (such as NADPH oxidase, xanthine oxidase or the mitochondrial respiratory chain) and antioxidant enzymes (such as superoxide dismutase, glutathione peroxidase, heme oxygenase, thioredoxin peroxidase/peroxiredoxin, catalase and paraoxonase). In addition, small-molecular-weight antioxidants might have a role in the defense against oxidative stress. Increased concentrations of reactive oxygen species reduce bioactive NO through chemical inactivation, forming toxic peroxynitrite, which in turn can uncouple endothelial NO synthase to form a dysfunctional superoxide-generating enzyme that contributes further to oxidative stress. The role of oxidative stress in vascular dysfunction and atherogenesis, and strategies for its prevention are discussed.
引用
收藏
页码:338 / 349
页数:12
相关论文
共 84 条
[1]   Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions - A possible peroxidative role for paraoxonase [J].
Aviram, M ;
Rosenblat, M ;
Bisgaier, CL ;
Newton, RS ;
Primo-Parmo, SL ;
La Du, BN .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (08) :1581-1590
[2]   Mitochondrial integrity and function in atherogenesis [J].
Ballinger, SW ;
Patterson, C ;
Knight-Lozano, CA ;
Burow, DL ;
Conklin, CA ;
Hu, ZY ;
Reuf, J ;
Horaist, C ;
Lebovitz, R ;
Hunter, GC ;
McIntyre, K ;
Runge, MS .
CIRCULATION, 2002, 106 (05) :544-549
[3]  
Barry-Lane PA, 2001, J CLIN INVEST, V108, P1513, DOI 10.1172/JCI200111927
[4]   Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease [J].
Blankenberg, S ;
Rupprecht, HJ ;
Bickel, C ;
Torzewski, M ;
Hafner, G ;
Tiret, L ;
Smieja, M ;
Cambien, F ;
Meyer, J ;
Lackner, KJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (17) :1605-1613
[5]  
Braunwald E, 2004, NEW ENGL J MED, V351, P2058
[6]   Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension [J].
Butler, R ;
Morris, AD ;
Belch, JJF ;
Hill, A ;
Struthers, AD .
HYPERTENSION, 2000, 35 (03) :746-751
[7]   Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice [J].
Dikalova, A ;
Clempus, R ;
Lassègue, B ;
Cheng, GJ ;
McCoy, J ;
Dikalov, S ;
Martin, AS ;
Lyle, A ;
Weber, DS ;
Weiss, D ;
Taylor, R ;
Schmidt, HHHW ;
Owens, GK ;
Lambeth, JD ;
Griendling, KK .
CIRCULATION, 2005, 112 (17) :2668-2676
[8]   Neutrophil superoxide anion-generating capacity, endothelial function and oxidative stress in chronic heart failure: Effects of short- and long-term vitamin C therapy [J].
Ellis, GR ;
Anderson, RA ;
Lang, D ;
Blackman, DJ ;
Morris, RHK ;
Morris-Thurgood, J ;
McDowell, IFW ;
Jackson, SK ;
Lewis, MJ ;
Frenneaux, MP .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (05) :1474-1482
[9]   Endothelial nitric oxide synthase in vascular disease -: From marvel to menace [J].
Förstermann, U ;
Münzel, T .
CIRCULATION, 2006, 113 (13) :1708-1714
[10]  
Fox KM, 2003, LANCET, V362, P782